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Abstract
Background: Surgical site infections following coronary artery bypass graft (CABG) procedures pose substantial
burden on patients and healthcare systems. This study aims to describe the incidence of surgical site infections and
causative pathogens following CABG surgery over the period 2003–2012, and to identify risk factors for complex
sternal site infections.
Methods: Routine computerised surveillance data were collected from three public hospitals in Queensland, Australia
in which CABG surgery was performed between 2003 and 2012. Surgical site infection rates were calculated by types
of infection (superficial/complex) and incision sites (sternal/harvest sites). Patient and procedural characteristics were
evaluated as risk factors for complex sternal site infections using a logistic regression model.
Results: There were 1,702 surgical site infections (518 at sternal sites and 1,184 at harvest sites) following 14,546 CABG
procedures performed. Among 732 pathogens isolated, Methicillin-sensitive Staphylococcus aureus accounted for 28.3%
of the isolates, Pseudomonas aeruginosa 18.3%, methicillin-resistant Staphylococcus aureus 14.6%, and Enterobacter
species 6.7%. Proportions of Gram-negative bacteria elevated from 37.8% in 2003 to 61.8% in 2009, followed by a
reduction to 42.4% in 2012. Crude rates of complex sternal site infections increased over the reporting period, ranging
from 0.7% in 2004 to 2.6% in 2011. Two factors associated with increased risk of complex sternal site infections were
identified: patients with an ASA (American Society of Anaesthesiologists) score of 4 or 5 (reference score of 3, OR 1.83,
95% CI 1.36-2.47) and absence of documentation of antibiotic prophylaxis (OR 2.03, 95% CI 1.12-3.69).
Conclusions: Compared with previous studies, our data indicate the importance of Gram-negative organisms as
causative agents for surgical site infections following CABG surgery. An increase in complex sternal site infection
rates can be partially explained by the increasing proportion of patients with more severe underlying disease.
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Background
Surgical site infections (SSIs) following coronary artery
bypass graft (CABG) procedures pose substantial burden
on patients and healthcare systems, particularly from
serious infections at sternal sites (e.g. deep incisional and
organ/space SSIs). The total length of stay for patients
with SSIs after CABG surgery is significantly longer than
those without SSIs [1]. The estimated excess costs associ-
ated with deep sternal site infections were over $20,000
per patient in the late 1990s [2,3] and are likely to be sub-
stantially greater now.
There are known host (e.g. advanced age, obesity and
diabetes) and procedural factors (e.g. wound class, dur-
ation of procedures and surgical technique) associated
with increased risk of SSIs [4-8]. A number of effective
infection control strategies can assist in reducing SSIs, in-
cluding appropriate antibiotic prophylaxis, effective patient
skin preparation, and surveillance of SSIs with feedback of
appropriate data to surgeons and hospitals [4,9].
Many countries have implemented standardised sur-
veillance systems to monitor and report SSIs after spe-
cific procedures, largely based on surveillance methods
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developed by the US Centres for Disease Control and
Prevention (CDC) National Healthcare Safety Network
(NHSN, formerly the National Nosocomial Infections
Surveillance System, NNISS) [5]. In Australia, while there
is no national level surveillance system in place, states
and territories have instituted surveillance programs for
monitoring healthcare-acquired infections (HAIs) [10].
Previous analysis of SSI surveillance data (2001–2005)
from Queensland, Australia found the NNISS risk index
was insufficient as a risk stratification tool for SSIs, and
suggested investigation of risk factors for procedure-
specific SSIs [11].
In this paper we describe the incidence of surgical site
infections and causative pathogens following CABG pro-
cedures in three Australian hospitals over the period
2003–2012, and examine risk factors for complex sternal
site infections.
Methods
Study population and surveillance data collection
The Centre for Healthcare Related Infection Surveillance
and Prevention (CHRISP) initiated a standardised, compu-
terised HAI surveillance system (the Electronic Infection
Control Assessment Technology, eICAT) during 2001
in public hospitals in Queensland, Australia [12]. There
were 166 public acute hospitals in Queensland, only
three of which had capacity to perform CABG surgery.
Surveillance data on SSIs following CABG procedures
from these three hospitals have been provided to CHRISP
since introduction of the system. The surveillance system
did not cover private hospitals in Queensland. We ana-
lysed data collected from 2003 to 2012 to take advantage
of a more robust data collection system following an initial
two year implementation phase (2001–2002).
Active patient-based surveillance was undertaken by
infection control practitioners in participating hospitals
to identify eligible patients undergoing CABG procedures
and follow up SSI cases. Patients meeting the following
criteria were included: 1) aged 14 years or older; 2) under-
going a CABG procedure that was defined by Inter-
national Statistical Classification of Diseases and Related
Health Problems, 10th Revision, Australian Modification/
Australian Classification of Health Interventions, 6th
Edition (ICD-10-AM/ACHI, Block codes 672, 673, 674)
[13]. The scope of CABG procedures was consistent with
the CDC NHSN definition [14]; 3) survival ≥ 48 hours
post procedure; and 4) the procedure was classified as
clean or clean-contaminated. Post-discharge surgical site
surveillance was conducted using a postal survey of patients
30 days after CABG procedures. Overall response rates for
the postal survey ranged from 69% to 75% across hospitals,
with relatively stable response rates over time. Cases of SSIs
were identified based on the CDC definitions [15,16], which
was endorsed by the Australian Commission on Safety and
Quality in Healthcare [17]. Data quality assurance proce-
dures were implemented routinely to ensure accuracy,
completeness and consistency of data in the eICAT.
Reports containing individual hospital and aggregated
state data were provided to participating hospitals on a six-
monthly basis, as part of strategies to improve infection
control practice.
Ethical approval was granted from the Queensland
Health Central Health and Medical Research Human
Research and Ethics Committee.
Microbiology
Microbiological testing was conducted by the three la-
boratories attached to the hospitals performing cardiac
surgery. All three laboratories were managed by Pathology
Queensland and shared common methods. Antimicrobial
susceptibility testing conformed to the recommendations
of the CLSI (Clinical and Laboratory Standards Institute)
except after June 2012 when all laboratories adopted the
EUCAST (The European Committee on Antimicrobial
Susceptibility Testing) system of interpretative criteria.
Surveillance data
Infection outcomes were categorised in terms of detection
time, infection types, and incision sites. Infections were
classified as in-hospital SSIs if occurring during the hos-
pital stay, or post-discharge SSIs if detected after discharge
and within 30 days post procedure (in case of implant in
situ, the follow-up period was within one year). Infections
also were classified as either superficial (involving skin/
subcutaneous tissue) or complex (involving deep soft tis-
sue, organ/space) infections [15]. Infections were recorded
as sternal or harvest site infections.
Potential risk factors were submitted on the eICAT sur-
veillance system and examined for their association with
SSIs following CABG procedures: 1) patient characteristics
including age, sex and American Society of Anaesthe-
siologists (ASA) score [18]. ASA score ranges from 1 to 5,
indicating a patient being healthy (1), with mild systemic
disease (2), with severe systemic disease (3), with severe
systemic disease that is a constant threat to life (4), or a
moribund patient who is not expected to survive without
the operation (5); and 2) procedural factors such as priority
of surgery (emergency vs. elective), types of CABG sur-
gery, wound classification (clean vs. clean-contaminated),
number of grafts, and use of antibiotic prophylaxis. Local
infection control practitioners reviewed medical records
and medication charts to determine whether prophylactic
antibiotics were given for the operative procedure with
the intent of preventing infection at the surgical site.
Procedure duration documented in the eICAT system was
excluded from use in our analysis, due to inconsistency of
date formatting applied to the start time and end time of
CABG surgery.
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Statistical analysis
Means, medians and proportions were used to summarise
continuous, binary and categorical data as appropriate.
The SSI rate was calculated as the number of infections
per 100 procedures. 95% confidence intervals were pro-
vided to facilitate comparison of crude SSI rates.
A univariate logistic regression was performed to assess
association of each of the potential risk factors with com-
plex sternal site infections. Robust estimates of standard
errors were employed to accommodate clustering of data
within hospitals. Variables with p < 0.25 were considered
as candidate risk factors to be included in a multivariate
logistic regression model.
The multivariate logistic regression model was con-
structed using a backward selection approach with robust
estimates of standard errors. Variables were eligible for
removal at p ≥0.05. The Hosmer-Lemeshow test was
employed to assess the goodness-of-fit for the model
(p > 0.05 indicating good fit). Predictive performance of
the model was evaluated by using a c-index derived
from the area under the receiver operating characteristic
(ROC) curve. The c-index ranges from 0.5 to 1.0, indi-
cating predictive ability from no better than chance to
perfect. The final model was internally validated based
on 100 bootstrap samples [14]. All data analysis was
performed using Stata (version 12.1, StataCorp, TX).
Results
Demographic and clinical characteristics of patients
undergoing CABG surgery
Over the period 2003–2012, a total of 14,517 patients
underwent CABG surgery (Table 1). Patients were pre-
dominantly male (78.4%), with a median age of 66 years.
CABG surgery was mainly elective (89.8%) and performed
with both sternal and graft site incisions (93.9%). The
mean number of grafts was 2.9. The majority of patients
were recorded as having an ASA score of 3 or 4, a clean
wound, and antibiotic prophylaxis administered. Absence
of antibiotic prophylaxis was documented in a minority of
cases (3.3%), which was more likely to occur in emergent
cases or in patients with severe underlying disease (indi-
cated by an ASA score of 5).
SSIs following CABG procedures
Twenty-nine of the 14,517 patients had a repeat CABG
surgery over the reporting period, resulting in a total of
14,546 sternal site incisions, and 15,781 harvest site
incisions (Table 2).
Among 14,546 sternal site incisions, 518 infections (3.6%)
were identified, with one half of the cases detected in-
hospital and the other half post-discharge. Of those sternal
site infections, 187 (36.1%) were classified as complex SSIs.
The complex sternal site infection rate was 1.3%.
For 15,781 harvest site incisions, 1,184 infection cases
(7.5%) were reported, most of which were detected follow-
ing discharge from hospital (72.6%), and were classified as
superficial (96.6%).
Table 1 Demographic and clinical characteristics of
patients undergoing coronary artery bypass graft (CABG)
procedures, 2003-2012
Characteristic* N %
Number of hospitals 3




















CABG with both sternal and graft site incisions 13,637 93.9




Mean number of grafts 2.9









*Five variables with missing values: ASA score (128, 0.9%), priority of surgery
(159, 1.1%), wound classification (3, 0.02%), category of graft numbers (25,
0.2%), and antibiotic prophylaxis (200, 1.4%).
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Table 2 Surgical site infections following coronary artery bypass graft procedures, by infection type and detection
time, 2003–2012
Infection type/detection time Sternal site incisions (N = 14,546)# Harvest site incisions (N = 15,781)
n Rate* (95% CI) % n Rate* (95% CI) %
Superficial SSIs 331 2.3 (2.0-2.5) 1,144 7.3 (6.9-7.7)
In-hospital 151 1.0 (0.9-1.2) 45.6 299 1.9 (1.7-2.1) 26.1
Post-discharge 180 1.2 (1.1-1.4) 54.4 845 5.4 (5.0-5.7) 73.9
Complex SSIs 187 1.3 (1.1-1.5) 40 0.3 (0.2-0.4)
In-hospital 111 0.8 (0.6-0.9) 59.4 25 0.2 (0.1-0.2) 62.5
Post-discharge 76 0.5 (0.4-0.7) 40.6 15 0.1 (0.1-0.2) 37.5
All infections 518 3.6 (3.3-3.9) 1,184 7.5 (7.1-7.9)
In-hospital 262 1.8 (1.6-2.0) 50.6 324 2.1 (1.8-2.3) 27.4
Post-discharge 256 1.8 (1.6-2.0) 49.4 860 5.5 (5.1-5.8) 72.6
*Per 100 procedures.
#The total number of sternal site incisions (14,546) were more than the total number of patients (14, 517), as 29 patients underwent a repeat CABG surgery over
the reporting period.
Table 3 Pathogens causing surgical site infections following coronary artery bypass graft procedures, 2003-2012
Pathogen
All surgical site infections Complex sternal site infections
n % n %
Total number of infections 1,702 187
Number of infections with pathogens isolated 732 152
Gram-positive - subtotal 388 53.0 107 70.4
Methicillin-sensitive Staphylococcus aureus 207 28.3 50 32.9
Methicillin-resistant Staphylococcus aureus 107 14.6 20 13.2
Coagulase-negative Staphylococci 46 6.3 30 19.7
Enterococcus spp. 11 1.5 5 3.3
Streptococcus spp. 10 1.4 1 0.7
Bacillus spp. 3 0.4 - -
Peptostreptococcus spp. 3 0.4 - -
Corynebacterium spp. 1 0.1 1 0.7
Gram-negative - subtotal 323 44.1 41 27.0
Pseudomonas aeruginosa 134 18.3 5 3.3
Enterobacter spp. 49 6.7 9 5.9
Serratia marcescens 38 5.2 9 5.9
Escherichia coli 23 3.1 3 2.0
Klebsiella spp. 21 2.9 8 5.3
Proteus mirabilis 13 1.8 2 1.3
Morganella morganii 11 1.5 1 0.7
Other Pseudomonas spp. 14 1.9 - -
Citrobacter spp. 8 1.1 2 1.3
Acinetobacter baumannii 5 0.7 1 0.7
Other Gram-negative bacteria* 7 1.0 1# 0.7
Fungi - subtotal 21 2.9 4 2.6
Candida albicans 20 2.7 4 2.6
Aspergillus spp. 1 0.1 - -
*including Providencia stuartii, Stenotrophomonas maltophilia, Aeromonas spp., Bacteroides fragilis, and Hafnia alvei.
#Hafnia alvei as the pathogen.
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Pathogens causing SSIs
From 1,702 infections at either sternal or harvest sites,
732 cases (43.0%) had pathogenic organisms isolated
(Table 3). Overall, Gram-positive bacteria were responsible
for 53.0% of infections, Gram-negative bacteria 44.1%, and
fungi (e.g. Candida albicans) 2.9%. Methicillin-sensitive
Staphylococcus aureus (MSSA) were isolated from 28.3%
of infection cases, followed by Pseudomonas aeruginosa
(18.3%), methicillin-resistant Staphylococcus aureus (MRSA,
14.6%) and Enterobacter spp. (6.7%). Proportions of SSIs
caused by Gram-negative organisms increased from 37.8%
in 2003 to 52.2% in 2006 and 61.8% in 2009, followed by a
reduction to 42.4% in 2012 (Figure 1).
From 187 complex sternal site infections (Table 3),
152 (81.3%) had pathogenic organisms isolated. Gram-
positive bacteria (e.g. MSSA, MRSA and coagulase-
negative Staphylococci) contributed to 70.4% of the infec-
tions, Gram-negative bacteria (e.g. Serratia marcescens,
Enterobacter spp., Klebsiella spp., Pseudomonas aeruginosa)
27.0%, and Candida albicans 2.6%.
Risk factors for complex sternal site infections
The univariate analysis (Table 4) identified five variables
as potential risk factors: ASA score of 4/5, emergency
surgery, CABG with sternal site incisions only, number
of grafts, and absence of documentation of antibiotic
prophylaxis. Two of these variables were retained in the
multivariate logistic regression model as risk factors for
complex sternal site infections (Table 5): ASA score of 4
or 5 (in relation to score of 3, OR 1.83, 95% CI 1.36-2.47)
and absence of documentation of antibiotic prophylaxis
(OR 2.03, 95% CI 1.12-3.69).
Trend in rates of complex sternal site infections over time
An overall upward trend in crude rates of complex sternal
site infections was observed over the reporting period, ran-
ging from 0.7% in 2004 to 2.6% in 2011 (Figure 2). There
was a substantial increase in the proportion of CABG pa-
tients with ASA score of 4/5 (from 18.1% in 2003 to 71.3%
in 2012, Figure 2). Proportions of patients with absence
of documentation of antibiotic prophylaxis fluctuated
between 1.8% and 4.8% over the reporting period.
Discussion
The complex sternal site infection rate (1.3%) in our study
is comparable with findings from the HAI surveillance
system in Norway (1.1%, 2,440 CABG procedures) [19] and
the NHSN system in the US (1.2%, 133,503 procedures)
[14]. Characteristics of patients and CABG procedures
were similar across these three study settings in terms
of compositions of gender, age and wound classification,
and proportions of emergency procedures. However, a
higher proportion of patients with ASA score of 4/5 (73%)
was reported by the NHSN system, as compared to those
from the Norwegian (27%) and our data (45%), indicating
a higher severity of underlying disease among patients
undergoing CABG surgery captured in the NHSN system.
Furthermore, the complex sternal site infections reported
by the NHSN excluded cases detected during post-
discharge surveillance (cases detected at readmission
were included), due to concern of inconsistency in post-
discharge case finding across 293 participating hospitals.
In contrast, both in-hospital and post-discharge detected
infection cases were included in Norwegian and our data,
where post-discharge SSI surveillance data were collected
Figure 1 Distribution of pathogens causing surgical site infections following coronary artery bypass graft procedures, 2003–2012.
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Table 5 Multivariate analysis of risk factors for complex sternal site infections following coronary artery bypass graft
procedures, Queensland public hospitals, 2003-2012
Risk factor Odd ratio 95% CI p Goodness-of-fit C-index
ASA (American Society of Anaesthesiologists) score 0.797 0.588*
3 Referent
4/5 1.83 1.36 – 2.47 <0.0001
Antibiotic prophylaxis
Yes Referent
No 2.03 1.12 – 3.69 0.020
*Validation of the model based on 100 bootstrap samples achieved a mean c-index of 0.579 (95% CI: 0.576 – 0.583), indicating good internal validation.
Table 4 Univariate analysis of risk factors for complex sternal site infections following coronary artery bypass graft
procedures, Queensland public hospitals, 2003-2012
Risk factor Crude rate (per 100 procedures) Odd ratio 95% CI p
Sex
Female 1.2 Referent
Male 1.3 1.05 0.73 – 1.49 0.796
Age category, years
<55 1.2 Referent
55-64 1.2 0.98 0.61 – 1.57 0.938
65-74 1.3 1.08 0.69 – 1.68 0.742
75+ 1.5 1.29 0.81 – 2.07 0.286
ASA (American Society of Anaesthesiologists) score
1/2 0.6 0.59 0.08 – 4.29 0.606
3 1.0 Referent
4/5 1.7 1.73 1.29 – 2.32 <0.0001
Priority of surgery
Elective 1.2 Referent
Emergency 1.7 1.40 0.92 – 2.14 0.120
CABG types
CABG with both sternal and harvest site incisions 1.2 Referent
CABG with sternal site incisions only 2.3 1.87 1.17 – 2.99 0.009
Wound classification
Clean 1.3 Referent
Clean-contaminated 0.9 0.67 0.17 – 2.72 0.575
Number of grafts
1 1.8 1.54 0.97 – 2.44 0.068
2 1.2 1.01 0.68 – 1.51 0.945
3 1.2 Referent
4 1.5 1.30 0.89 – 1.88 0.171
5+ 1.0 0.82 0.39 – 1.71 0.599
Antibiotic prophylaxis
Yes 1.2 Referent
No 2.6 2.09 1.15 – 3.78 0.015
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from a relatively small number of participating hospitals
(six and three respectively).
Our data indicate the importance of Gram-negative
bacteria as causative agents for SSIs following CABG
procedures. As observed in three participating hospitals,
proportions of all SSIs (superficial and complex at both
the sternal and harvest sites) caused by Gram-negative
organisms increased from 38% in 2003 to 62% in 2009,
despite a reduction to 42% in 2012. Harrington and
colleagues [6] reported that Gram-negative bacilli were
isolated from 18% of SSIs after CABG surgery, based on
surveillance data collected during 1998–2001 in Victoria,
Australia, while the corresponding figure based on our
surveillance data over 2003–2012 was 44%. Further
analysis of pathogens causing complex sternal site in-
fections in our study showed Gram-negative bacteria
were responsible for 27% of these serious infections,
which is consistent with recently published NHSN data
(Gram-negative organisms accounting for 34% of path-
ogens in complex SSIs after CABG surgery) [20]. An
earlier study conducted in the US during 2000–2004
found 11% of sternal SSIs were caused by Gram-negative
aerobes [21]. The apparently increasing proportion of
CABG surgical site infections caused by Gram-negative
organisms has important implications for clinical practice.
Widely used guidelines (for example, the Sanford Guide
to Antimicrobial Therapy) recommend cefazolin, cefur-
oxime or vancomycin as perioperative prophylaxis for
cardiovascular surgery [22]. The current Australian Thera-
peutic Guidelines recommend three options for antibiotic
prophylaxis in cardiac surgery: cefazolin alone, a combin-
ation of flucloxacillin and gentamicin, or a combination of
vancomycin and gentamicin [23]. Psedomonas aeruginosa
is intrinsically resistant to first generation cephalosporins.
Other major Gram-negative organisms reported in our
study (e.g. Enterobacter spp. and Serratia marcescens) be-
long to a genus whose inducible beta-lactamase produc-
tion is a common property [9]. Given the increased
prevalence of Gram-negative organisms associated with
SSIs, we believe that cardiac surgeons should consult with
their microbiologists to discuss local antibiograms prior to
selecting surgical prophylactic antibiotics for patients
undergoing CABG procedures.
Patient-based active surveillance data on CABG proce-
dures provide an opportunity to investigate the long term
trend in SSI rates. An increase in complex sternal site
infection rates over 2003–2012 can be partially explained
by variation in case mix of patients. There was a substan-
tial increase in the proportion of patients with ASA score
of 4/5 (indicating severe underlying disease) from 18%
to 71% over the last decade. This might reflect the
changing landscape of coronary intervention characterised
by more patients with coronary artery disease undergoing
treatment by percutaneous revascularisation (e.g. balloon
angioplasty and stenting), while surgical revascularisation
(CABG) is reserved for patients with more comorbid
conditions and more severe underlying disease [24]. This
study provides evidence on the increased risk of surgical
site infections driven by increasing severity of illness
among the patient population electing for CABG surgery.
The relatively poor discriminatory ability of the NNIS
risk index for CABG surgical site infections has been widely
reported across various study settings [11,14,19,25-27]. The
underlying reason is that nearly all patients undergoing
CABG surgery would have an ASA score ≥ 3 and have
wound classification of clean or clean-contaminated,
leaving the NNIS risk index differentiating patients just
based on the procedure duration (top quartile vs. the
Figure 2 Trends in complex sternal site infection rates following coronary artery bypass graft procedures, and proportions of patients
with ASA (American Society of Anaesthesiologists) score of 4/5, 2003–2012.
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rest). In this study, we re-categorised the ASA score
into three groups (1/2, 3, and 4/5) to differentiate host
susceptibility to infection for epidemiological purposes.
Use of alternative risk scores (such as the EuroSCORE
[26] and the Admission-specific Chronic Disease Scores
[25]) has been associated with improved predictive per-
formance for SSIs following CABG procedures. However,
construction of these risk scores requires extensive and
complex clinical data; their application to routine SSI
surveillance data is subject to advancements of the
underlying surveillance systems.
There is increasing interest in developing risk adjustment
models for appropriate comparison of SSI rates following
CABG surgery as part of publicly available hospital per-
formance metrics. A recently published risk adjustment
model based on the NHSN surveillance data included five
predictors (ASA score, procedure duration, medical school
affiliation, and interaction of age and sex) [14], achieving
predictive performance of 0.62 (c-index) for complex
sternal site infections after CABG surgery. A similar
study (from Victoria, Australia) reported a predictive
performance of 0.64 (c-index) for a model containing
two predictors: diabetes, and body mass index (BMI > 35)
[27]. In our study, a logistic regression model with two
independent predictors (ASA score; absence of docu-
mentation of antibiotic prophylaxis) reported a c-index of
0.59 in predicting complex sternal site infections following
CABG surgery. It appears that inclusion of a common set
of patient/procedural factors such as ASA score, proced-
ure duration, diabetes status, obesity (BMI) and antibiotic
prophylaxis status in a risk adjustment model would
enhance our understanding of the extent to which these
factors contribute to and predict the SSIs after CABG
surgery. However, none of the models mentioned above
was able to test this full set of potentially important
predictors, due to lack of data on one or more factors
in their respective HAI surveillance systems. As not
reaching a c-index of 0.7, considered to be indicative of
acceptable predictive performance, those risk adjustment
models may not be sufficient for appropriate comparison
of infection rates across hospitals.
There were some limitations associated with our HAI
surveillance data. First, the standardised surveillance data
on CABG surgical site infections were collected from a
total of three public hospitals which had capacity to pro-
vide CABG surgery for all public patients in Queensland.
However, patients undergoing CABG at private hospitals
(accounting for approximately 40% of the total patients)
[28] were excluded from surveillance, thus limiting our
ability to generalise findings to the patient population
in Queensland as a whole. Second, there was concern
regarding inconsistency in detecting SSIs (particularly
the superficial infections) at post-discharge surveillance,
due to inter-hospital variation in terms of completeness
of follow-ups and potentially unreliable diagnosis of
infections based on patient self-reporting [29]. This can
be partly addressed by focusing on complex sternal site
infections, which are more likely to be reported by patients
at post-discharge surveillance and diagnosed by clinicians.
Our data indicated 41% of complex sternal site infections
were detected following discharge. In addition, complex
sternal site infections have a greater consequence for
patients. Third, procedure duration was not included as
a potential risk factor for CABG surgical site infections
due to concern with inconsistency in collecting this in-
formation, thus limiting our ability to assess its role in
predicting surgical site infections.
With transition of the eICAT to a more sophisticated
Multiprac© surveillance system in Queensland Health,
which features automatic linkages to multiple patient
demographic and clinical databases, additional data on
relevant risk factors (e.g. diabetes status, isolated CABG
procedures or in conjunction with valve replacements)
and infection outcomes will be routinely collected. There
is scope to further refine our logistic regression model for
risk adjustment, and to assist ongoing monitoring, public
reporting, and improving surgical site infection control
practice in hospitals.
Conclusions
Our analysis of 10 years of CABG surgical site infection
surveillance data indicates the importance of Gram-
negative organisms as causative pathogens, and emphasises
the need to select appropriate prophylactic antibiotics for
patients undergoing CABG procedures. An upward trend
in complex sternal site infection rates can be partially
explained by the increasing proportion of CABG patients
with more severe underlying disease. Future research
should focus on development of appropriate and adequate
risk adjustment models to facilitate valid comparison of
CABG surgical site infection rates across hospitals.
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